GSK, A*STAR to jointly develop new medicines for emerging markets

01:02 EDT 9 Apr 2013 | Pharmaceutical Business Review

GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical Engineering and Sciences (ICES) have collaborated to jointly develop new medicines targeting emerging markets.

Original Article: GSK, A*STAR to jointly develop new medicines for emerging markets

NEXT ARTICLE

More From BioPortfolio on "GSK, A*STAR to jointly develop new medicines for emerging markets"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Searches Linking to this Story